Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Oncology Letters|March 22, 2016
Totally laparoscopic D2 radical distal gastrectomy using Billroth II anastomosis: A case reportKetao Jin, Huanrong Lan, Feng Tao, et al.Experimental and Therapeutic Medicine|December 20, 2012
Antitumor effect of FP3 in a breast cancer xenograft modelHuanrong Lan, Lingzhi Zheng, Ketao Jin, et al.Hepato-Gastroenterology|June 14, 2011
Heterogeneity in primary colorectal cancer and its corresponding metastases: a potential reason of EGFR-targeted therapy failure?Zhongqi Li, Ketao Jin, Huanrong Lan, et al.Hepato-Gastroenterology|April 28, 2015
Laparoscopic gastrectomy for gastric cancer in China: an overviewHuanrong Lan, Naibiao Zhu, Yuefu Lan, et al.Cancers|April 13, 2023
Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway InhibitorsMin Chen, Huanrong Lan, Shiya Yao, et al.Oncology Letters|February 6, 2019
A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft modelZhonghai Guan, Huanrong Lan, Dan Sun, et al.International Immunopharmacology|July 23, 2024
Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered formsHuan Bao, Yun Chen, Youni Zhang, et al.International Immunopharmacology|October 12, 2020
An update on colorectal cancer microenvironment, epigenetic and immunotherapyKetao Jin, Chengcheng Ren, Yuyao Liu, et al.Frontiers in Immunology|November 3, 2023
It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancerShiya Yao, Yuejun Han, Mengxiang Yang, et al.Drug Delivery|September 1, 2020
Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspectiveHuanrong Lan, Wei Zhang, Ketao Jin, et al.Pageof 5